| Literature DB >> 22921012 |
Gabriela Benavides Valades1, Andre Ganswindt, Henry Annandale, Martin L Schulman, Henk J Bertschinger.
Abstract
BACKGROUND: In southern Africa, various options to manage elephant populations are being considered. Immunocontraception is considered to be the most ethically acceptable and logistically feasible method for control of smaller and confined populations. In this regard, the use of gonadotropin-releasing hormone (GnRH) vaccine has not been investigated in female elephants, although it has been reported to be safe and effective in several domestic and wildlife species. The aims of this study were to monitor the oestrous cycles of free-ranging African elephant cows using faecal progestagen metabolites and to evaluate the efficacy of a GnRH vaccine to induce anoestrus in treated cows.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22921012 PMCID: PMC3485135 DOI: 10.1186/1477-7827-10-63
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Mean faecal progesterone metabolite concentrations ± SD of female African elephants
| 30+ | LE | T | 64 | 1.96 ± 0.86 | 4.83 ± 3.44 | 1.27 ± 0.34 | |
| 30+ | LE | T | 56 | 3.03 ± 1.16 | 6.32 ± 3.55 | 2.09 ± 0.64 | |
| 25 | LE | T | 64 | 3.13 ± 1.39 | 6.18 ± 3.35 | 2.03 ± 0.76 | |
| 20 | LE | T | 50 | 2.63 ± 1.23 | 5.47 ± 2.76 | 1.64 ± 0.42 | |
| 18 | LE | T | 59 | 3.10 ± 1.30 | 6.13 ± 3.50 | 1.93 ± 0.69 | |
| 15 | LE | T | 59 | 1.81 ± 0.75 | 4.28 ± 2.04 | 1.30 ± 0.35 | |
| 12 | LE | C | 59 | 2.34 ± 1.30 | 5.84 ± 3.57 | 1.33 ± 0.54 | |
| 10 | LE | C | 63 | 1.53 ± 0.55 | 3.80 ± 2.73 | 1.10 ± 0.27 | |
| 30+ | UE | T | 25 | 2.90 ± 1.25 | 11.12 ± 15.94 | 1.96 ± 0.58 | |
| 30+ | UE | T | 27 | 2.39 ± 1.13 | 11.33 ± 17.75 | 1.70 ± 0.43 | |
| 15 | UE | C | 20 | 3.36 ± 1.25 | 5.89 ± 2.56 | 2.54 ± 0.75 | |
| 15 | UE | C | 20 | 2.82 ± 1.25 | 8.28 ± 6.37 | 1.83 ± 0.59 | |
aLE = Lower Escarpment; UE = Upper Escarpment.
bT = GnRH treatment; C = Control.
cFPM = faecal progestagen metabolite.
dmean ± SD.
epZP treatment 2004-2007.
Summary of oestrous cycle lengths in weeks of female African elephants of the Lower Escarpment herd
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-treatment | 4.43* | 8.43 | 5.71* | | | | | | |
| 9.57+ | 7.86+ | 7.14+ | | | | | | ||
| | | | | | |||||
| Post-treatment | 9.00N | 6.00 | | 10.00 | 25.86+ | 15.86+ | 10.43N | 16.86+ | |
| 3.86N | 8.86+ | | 1.71* | | | 5.29N | | ||
| | |||||||||
| 5.57* | 8.71N | | 10.14 | | | 10.57 | | ||
| 2.43* | 6.00N | | 0.71* | | | 2.14* | | ||
| | | | | ||||||
| 9.43N | | | 12.14 | | | | | ||
| 3.71N | | | 2.43* | | | | | ||
aLP = Luteal phase; ILP = Inter-luteal phase; TC = Total cycle length.
bGnRH treatment.
cControl.
* = short phase; + = long phase; N = normal cycle.
Figure 1Faecal progestagen metabolite concentrations for two adult female African elephants.a) Female No. 1 treated with the GnRH vaccine and b) Female No. 4; control group. Solid line represents baseline concentration, horizontal solid bars represent luteal phase, horizontal open bars represent inter-luteal phase, and dotted line arrows correspond to darting dates of primary vaccine and subsequent booster vaccine. Circles stand for sniffing into genital opening or urine and stars for vaginal discharge observations. Wet season is illustrated in grey background.
Figure 2Scatter plot of faecal progesterone metabolite concentrations from 12 female African elephants during one-year study. Circles represent individuals from the Lower Escarpment herd (n = 8) and triangles represent individuals from the Upper Escarpment herd (n = 4). Line represents overall mean monthly FPM concentration. Vertical bars represent mean monthly rainfall corresponding to the study period for the Lower Escarpment (dark grey bars) and Upper Escarpment (light grey bars).